Renewing Onivyde (Irinotecan Liposome) Approval with Blue Cross Blue Shield in Virginia: Annual Review Requirements and Timeline

Answer Box: Renewing Your Onivyde Coverage

Anthem Blue Cross Blue Shield Virginia requires annual prior authorization renewal for Onivyde (irinotecan liposome). Start the renewal process 30-45 days before your current authorization expires to avoid treatment interruptions. Your oncologist must submit updated clinical documentation through Availity Essentials showing continued medical necessity, disease response, and adherence to FDA-approved indications. If your authorization lapses, contact the Ipsen Cares Patient Assistance Program immediately for bridge therapy while pursuing expedited renewal.

First step today: Check your current authorization expiration date on your Anthem member portal or call Provider Services at 800-901-0020.

Table of Contents

Renewal Triggers: When to Start Early

Anthem Blue Cross Blue Shield Virginia's annual renewal system means your Onivyde authorization will expire exactly 12 months from approval. However, certain situations require starting the renewal process even earlier:

Standard Timeline

  • 45 days before expiration: Ideal time to begin gathering documentation
  • 30 days before expiration: Latest recommended submission date
  • 15 days before expiration: Request expedited review if not yet submitted

Early Renewal Triggers

Start your renewal process 60-90 days early if you experience:

  • New side effects requiring dose modifications
  • Changes in disease status (progression or response)
  • Upcoming formulary changes (typically announced in October for January implementation)
  • Previous renewal delays or denials with your plan
Tip: Set a calendar reminder for 60 days before your expiration date. Treatment interruptions can significantly impact pancreatic cancer outcomes.

Evidence Update Requirements

Anthem requires comprehensive clinical documentation proving ongoing medical necessity. Your oncologist must provide updated evidence in four key areas:

Disease Status Documentation

Required elements:

  • Current imaging results with RECIST 1.1 criteria measurements
  • Progression-free survival calculation from treatment initiation
  • Tumor marker trends (CA 19-9, CEA if applicable)
  • Performance status assessment (ECOG score)

RECIST Response Categories for Renewal:

  • Complete Response (CR): Continue current regimen
  • Partial Response (PR): Strong justification for continuation
  • Stable Disease (SD): Document clinical benefit and symptom control
  • Progressive Disease (PD): Requires new treatment plan or compassionate use justification

Treatment Response Evidence

Your renewal must demonstrate one of the following:

  1. Objective response (CR or PR by RECIST criteria)
  2. Disease stabilization with clinical benefit
  3. Symptom improvement with quality of life measures
  4. Lack of viable alternatives due to prior treatment failures

Safety and Tolerability Update

Document any adverse events and management:

  • Grade 2-4 diarrhea episodes and resolution
  • Neutropenia events and dose modifications
  • Any treatment interruptions and reasons
  • Current performance status and functional capacity

Adherence Verification

Anthem requires confirmation of:

  • Compliance with prescribed dosing schedule
  • Appropriate supportive care measures
  • Regular monitoring per FDA labeling
  • No contraindications to continued therapy

Renewal Documentation Packet

Core Required Documents

Submit through Availity Essentials with the following:

  1. Updated Prior Authorization Request Form
    • Current diagnosis with ICD-10 codes
    • Requested duration (typically 12 months)
    • Prescriber attestation of medical necessity
  2. Clinical Summary Letter
    • Treatment start date and duration
    • Response to therapy with objective measures
    • Current disease status with imaging dates
    • Rationale for continued therapy
  3. Recent Imaging Reports (within 8-12 weeks)
    • CT or MRI with RECIST measurements
    • Radiologist's assessment of response
    • Comparison to baseline and prior studies
  4. Laboratory Results (within 30 days)
    • Complete blood count with differential
    • Comprehensive metabolic panel
    • Liver function tests
    • Tumor markers if applicable
  5. Treatment History Documentation
    • Previous therapies tried and failed
    • Reasons for discontinuation
    • Contraindications to alternative treatments

Letter of Medical Necessity Template

Your oncologist should structure the renewal letter as follows:

Paragraph 1: Patient identification, diagnosis, and current treatment Paragraph 2: Treatment response with objective measures Paragraph 3: Continued medical necessity rationale Paragraph 4: Alternative treatment considerations Paragraph 5: Request for continued authorization

Clinician Corner: Reference FDA-approved indications, NCCN guidelines, and specific Anthem medical policy criteria in your letter. Include progression-free survival data and quality of life assessments when available.

Timeline and Submission Process

Anthem Virginia Renewal Timeline

Timeframe Action Required Responsible Party
60 days before Begin documentation gathering Clinic staff
45 days before Submit complete renewal packet Prescriber
30 days before Follow up if no response received Clinic/Patient
15 days before Request expedited review Prescriber
5 days before Initiate bridge therapy planning All parties

Submission Methods

  1. Primary: Availity Essentials portal (fastest processing)
  2. Secondary: Provider fax (verify current number with Anthem)
  3. Phone: 800-901-0020 for urgent cases or technical issues

Decision Timeline

  • Standard review: 14 business days from complete submission
  • Expedited review: 72 hours for urgent medical necessity
  • Incomplete submissions: Additional 5-10 days for missing documentation

If Your Authorization Lapses

Immediate Actions (Day 1-3)

  1. Contact Ipsen Cares: Call the patient assistance program for emergency bridge supply
  2. Submit expedited renewal: Request 72-hour urgent review through Availity
  3. Document medical urgency: Have your oncologist provide written justification for treatment continuation

Bridge Therapy Options

Ipsen Cares Patient Assistance Program:

  • Provides temporary medication supply during coverage gaps
  • Eligibility based on insurance status and financial need
  • Apply through healthcare provider or program website
  • Typical processing time: 3-5 business days

Escalation Steps

If standard renewal is denied:

Level 1: Peer-to-Peer Review

  • Request within 5 business days of denial
  • Oncologist discusses case directly with Anthem medical director
  • Success rate: ~40-60% for well-documented cases

Level 2: Internal Appeal

  • Submit within 30 days of denial notice
  • Include additional clinical evidence or expert opinions
  • Decision timeline: 30 days for standard, 72 hours for expedited

Level 3: External Review (Virginia)

  • File with Virginia State Corporation Commission Bureau of Insurance
  • Available within 120 days of final internal denial
  • Independent medical review by external experts
  • Cancer cases may bypass internal appeals per Virginia law
Note: Virginia law allows expedited external review for cancer treatment denials without completing internal appeals first.

Annual Plan Changes to Monitor

Formulary Updates (Effective January 1)

Monitor for changes that may affect your Onivyde coverage:

  • Tier placement changes: Movement to higher cost-sharing tiers
  • New restrictions: Additional prior authorization requirements
  • Step therapy updates: New required first-line treatments
  • Quantity limit modifications: Changes to per-cycle dosing limits

Plan Design Shifts

Benefits to verify annually:

  • Specialty drug copay amounts
  • Out-of-network coverage for administration
  • Site of care restrictions (hospital vs. clinic)
  • Maximum out-of-pocket limits

Notification Requirements

Anthem must provide 30 days advance notice for any negative formulary changes affecting current users. Watch for:

  • Member portal messages
  • Mailed notifications
  • Pharmacy benefit updates
  • Annual plan documents

Personal Renewal Tracker

Key Dates to Track

  • Current authorization expiration: ___________
  • Renewal submission deadline: ___________ (45 days prior)
  • Last imaging date: ___________
  • Next scheduled scan: ___________
  • Last lab work: ___________

Documentation Checklist

  • Updated prior authorization form completed
  • Clinical summary letter from oncologist
  • Recent imaging reports (within 8-12 weeks)
  • Current laboratory results (within 30 days)
  • Treatment history documentation
  • Insurance card and member ID verified

Contact Information

  • Anthem Provider Services: 800-901-0020
  • Availity Technical Support: ___________
  • Ipsen Cares Program: ___________
  • Virginia Bureau of Insurance: 1-877-310-6560

FAQ

How long does Anthem Virginia take to process Onivyde renewals? Standard renewals take 14 business days from complete submission. Expedited reviews for urgent cases are completed within 72 hours.

What happens if my renewal is denied? You have multiple appeal options: peer-to-peer review (within 5 days), internal appeal (within 30 days), and external review through Virginia's Bureau of Insurance (within 120 days). Cancer cases may qualify for expedited external review.

Can I continue treatment while my renewal is pending? If submitted before expiration, most patients can continue treatment during the review period. If authorization has lapsed, contact Ipsen Cares for bridge therapy options.

Does Anthem require step therapy for Onivyde renewals? For established patients showing clinical benefit, step therapy typically doesn't apply to renewals. However, verify your specific plan requirements as policies may vary.

What if my oncologist changes practices during renewal? The new practice must submit a complete renewal packet with treatment history from your previous provider. Allow extra time for this transition.

Are there any Virginia-specific renewal requirements? Virginia law provides additional protections for cancer patients, including expedited external review options and stronger notification requirements for formulary changes.


Counterforce Health helps patients, clinicians, and specialty pharmacies navigate complex prior authorization and appeals processes. Our platform analyzes denial letters and plan policies to create targeted, evidence-backed appeals that turn insurance denials into approvals. By automating the identification of denial reasons and drafting point-by-point rebuttals aligned to each plan's specific requirements, we help ensure patients get timely access to necessary treatments like Onivyde.

The renewal process for specialty cancer medications like Onivyde requires careful attention to timing and documentation. When working with Counterforce Health's platform, healthcare providers can streamline this process by accessing templates that align with Anthem's specific requirements and automatically generate the clinical evidence needed for successful renewals.

Sources & Further Reading


Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies and coverage requirements may vary. Always consult with your healthcare provider and insurance company for specific guidance regarding your situation. For assistance with Virginia insurance issues, contact the State Corporation Commission Bureau of Insurance at 1-877-310-6560.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.